Salesforce.com to B...
Health Care: Drugs
BioDelivery Sciences International Inc. (BDSI: NASDAQ)
$3.17 -0.21 | -6.21%
06/04/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 16.10 | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 1.69 | 0.58 | 0.98 |
| Price to Sales (TTM) | 3.03 | 4.62 | 1.42 |
| Price to Book (MRQ) | 4.03 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 6.58 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | 13.60 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | 25.00 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 13,001.00 | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -4.20 | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 68.96 | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -12.78 | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 1.60 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 1.60 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.45 | 0.96 |
| Interest Coverage (TTM) | n.a. | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 96.10 | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | n.a. | 83.50 | 47.70 |
| EBITD Margin (TTM) | 12.70 | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | -85.63 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 18.10 | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -64.90 | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.18 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -65.40 | 5.30 | 7.00 |
| Return on Assets (TTM) | 12.90 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | -33.10 | 2.20 | 2.50 |
| Return on Investment (TTM) | 24.10 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | 190.50 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 1,946,897.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | 352,367.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | 70.50 | 5.80 | 7.60 |
| Inventory Turnover (TTM) | n.a. | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.80 | 0.40 | 0.40 |
Portfolios with BDSI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- UserWhole Portfolio
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks Under $5 Outperfo...
- Contributor10 Pharma Stocks With 100% ...
- UserSmall Cap Bargains to follo...
- UserPROS
- UserCloud66 - IRA
Latest BDSI Headlines from TheStreet
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- The Next Big Thing in Biotech: BIO CEO Conference
02.10.12 | 05:02 am - 10 Stocks Under $5 Outperforming in 2012 01.31.12 | 05:01 am
- Biotech Stock Mailbag: Adventrx Pharma 07.15.11 | 05:07 am
- BioDelivery Sciences International Inc. Stock Downgraded (BDSI) 04.01.11 | 06:04 pm
- IPO Watch: 2011 02.16.11 | 01:02 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- Rodman Rambles: Promising Biotechs 09.15.10 | 10:09 am
- Biotech Calendar: Key Dates for September 09.01.10 | 07:09 am
- Stock Offerings: MGIC Investment 04.20.10 | 11:04 am
Press Releases for BDSI
- BioDelivery Sciences To Present At The Jefferies 2012 Global Healthcare Conference - PR Newswire 05.31.12 | 07:05 am
- BioDelivery Sciences Receives $2.5 Million Milestone From Meda For BREAKYL In E.U. - PR Newswire 05.21.12 | 07:05 am
- BioDelivery Sciences Awarded Patent Resulting In $15 Million Milestone Payment - PR Newswire 04.17.12 | 07:04 am
- BioDelivery Sciences To Present At The Future Leaders In The Biotech Industry Conference - PR Newswire 04.16.12 | 08:04 am
- BioDelivery Sciences To Host Opioid Dependence Investor Event And Webcast On April 11, 2012 - PR Newswire 04.05.12 | 08:04 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Federal Court Grants Request By BioDelivery Sciences For Stay Of MonoSol Litigation - PR Newswire 03.14.12 | 07:03 am
- ONSOLIS Relaunch Postponed Pending Product Modification - PR Newswire 03.12.12 | 07:03 am
- US Patent Office Rejection Of All Claims In Final Asserted MonoSol Patent Further Supports BioDelivery Sciences' Position - PR Newswire 03.06.12 | 09:03 am
- BioDelivery Sciences To Present At Cowen And ROTH Conferences - PR Newswire 03.05.12 | 07:03 am
Partner Headlines for BDSI
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- Legal Developments Bode Well For BioDelivery Sciences - Seeking Alpha 03.15.12 | 08:03 am
- Biopharma Stocks To Watch This Week - Seeking Alpha 01.19.12 | 09:01 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- This Week's Healthcare Stock Watch - Seeking Alpha 09.20.11 | 09:09 am
- Options Brief: BioDelivery Sciences International (BDSI) - Benzinga 12.28.10 | 09:12 am
- BioDelivery Sciences: Signs of Life - Seeking Alpha 09.10.10 | 03:09 pm
- BioDelivery Sciences Hopes to Increase Access to Cancer-Pain Drug - Fox Business 09.02.10 | 05:09 pm
